• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠蜕膜组织纤溶酶原激活物抑制剂的一种分子变体。

A molecular variant of plasminogen activator inhibitor of rat decidual tissue.

作者信息

Tarachand U, Pawse A R

机构信息

Radiation Biology and Biochemistry Division, Bhabha Atomic Research Centre, Bombay, India.

出版信息

Biochem Mol Biol Int. 1995 Dec;37(6):1037-45.

PMID:8747533
Abstract

Artificially induced rat decidual tissue expresses plasminogen activator inhibitor (PAI). This PAI, isolated and purified employing chromatographic techniques, is a low molecular weight protein unlike the known PAIs. The final purified preparation resolves into a single band following SDS-PAGE and has an approximate molecular weight of 29 kDa. The properties studied include specificity for urokinase-type (uPA) and tissue-type (tPA) plasminogen activators, binding to conA and heparin, inhibition of thrombin, plasmin and trypsin. Decidual PAI is immunogenic in rabbit and a monospecific antiserum raised against the decidual inhibitor cross reacts with an extract of human placenta.

摘要

人工诱导的大鼠蜕膜组织表达纤溶酶原激活物抑制剂(PAI)。采用色谱技术分离纯化得到的这种PAI是一种低分子量蛋白质,与已知的PAI不同。最终纯化产物经SDS-PAGE后呈现为单一条带,其分子量约为29 kDa。所研究的特性包括对尿激酶型(uPA)和组织型(tPA)纤溶酶原激活物的特异性、与伴刀豆球蛋白A和肝素的结合、对凝血酶、纤溶酶和胰蛋白酶的抑制作用。蜕膜PAI在兔体内具有免疫原性,针对蜕膜抑制剂产生的单特异性抗血清与人类胎盘提取物发生交叉反应。

相似文献

1
A molecular variant of plasminogen activator inhibitor of rat decidual tissue.大鼠蜕膜组织纤溶酶原激活物抑制剂的一种分子变体。
Biochem Mol Biol Int. 1995 Dec;37(6):1037-45.
2
Characterization of urokinase-type plasminogen activator of rat decidual tissue.大鼠蜕膜组织尿激酶型纤溶酶原激活剂的特性研究
Biochem Mol Biol Int. 1994 Jul;33(4):775-84.
3
Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.孕激素抑制而凝血酶刺激足月蜕膜基质细胞中的纤溶酶原激活物/抑制物系统:对分娩的影响。
Am J Obstet Gynecol. 2007 Apr;196(4):382.e1-8. doi: 10.1016/j.ajog.2007.02.035.
4
Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.组织型和尿激酶型纤溶酶原激活剂以及纤溶酶原激活剂抑制剂-1和-2在人和恒河猴胎盘中的表达
J Anat. 1999 Feb;194 ( Pt 2)(Pt 2):183-95. doi: 10.1046/j.1469-7580.1999.19420183.x.
5
Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.通过定点诱变鉴定1型纤溶酶原激活物抑制剂低分子量抑制剂的结合位点。
Biochemistry. 1998 Feb 3;37(5):1227-34. doi: 10.1021/bi971554q.
6
Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.肾细胞癌患者中尿激酶型纤溶酶原激活剂、尿激酶型纤溶酶原激活剂受体和纤溶酶原激活剂抑制剂的表达:与肿瘤相关巨噬细胞及预后的相关性
J Urol. 2005 Aug;174(2):461-5. doi: 10.1097/01.ju.0000165150.46006.92.
7
Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1.HTC大鼠肝癌细胞纤溶酶原激活物抑制剂-1的免疫亲和纯化
Thromb Haemost. 1987 Dec 18;58(4):1017-23.
8
Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.与尿激酶、其受体和纤溶酶原激活物抑制剂-1不同,上皮组织型纤溶酶原激活物的表达在慢性静脉溃疡中增加。
Br J Dermatol. 2004 Dec;151(6):1189-96. doi: 10.1111/j.1365-2133.2004.06261.x.
9
Spitz naevi may express components of the plasminogen activation system.斯皮茨痣可能表达纤溶酶原激活系统的成分。
J Pathol. 2002 Sep;198(1):92-9. doi: 10.1002/path.1167.
10
Expression and characterization of recombinant porcine plasminogen activator inhibitor-1.重组猪纤溶酶原激活物抑制剂-1的表达与鉴定
Thromb Haemost. 1997 Feb;77(2):350-6.